Hawkins (HWKN) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Hawkins

NasdaqGS•Basic Materials•Specialty Chemicals

$152.85+0.74(<0.01%)Pre-market

Market Cap

$3.17B

P/E

36.5x

P/S

2.8x

P/B

5.6x

Hawkins, Inc. operates as a water treatment and specialty ingredients company in the United States. The company operates through three segments: Water Treatment, Food and Health Sciences, and Industrial Solutions. The Water Treatment segment provides chemicals, filtration media and systems, equipment, services and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water, and agricultural water. This segment also sells and services equipment, including tanks, valves, and pumps. The Food and Health Sciences segment provide ingredient distribution, processing, and formulation solutions, such as base chemistry, acid-based reactions, minerals, vitamins and amino acids, excipients, botanicals and herbs, sweeteners and enzymes, fertilizers, and food-grade and pharmaceutical salts and ingredients to nutrition, food, pharmaceutical, and agricultural markets. The Industrial Solutions segment offers industrial chemicals, products, and services such as acids and alkalis, liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide to industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing industries. It also repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals. Hawkins, Inc. was founded in 1938 and is headquartered in Roseville, Minnesota.

How this company scores

GoodMetricSide Score: 72/100

Strongest: Growth (21/25); weakest: Cash & Earnings Quality (13/25).

Profitability20/25

Growth21/25

Balance Sheet & Red Flags18/25

Cash & Earnings Quality13/25

Strengths

High ROELow leverageImproving leverageConsistent growth

No red flags in the last 8 quarters.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 36.5x5y range 26.3x – 47.0x

Currently near its 20-quarter median.

P/S · 2.8x5y range 2.3x – 3.7x

Currently near its 20-quarter median.

P/B · 5.6x5y range 4.8x – 7.8x

Price & Volume

Market Cap $3.17B

Metrics at a Glance

as of September 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.12B
Q. Revenue: $313.82M
TTM EBITDA: $182.83M
TTM Op. Income: $129.26M
Q. Op. Income: $41.91M
TTM Net Income: $86.73M
Q. Net Income: $27.78M
EPS: $1.34
Shares Out.: $20.71M

$1.12B in TTM revenue grew 11.8% YoY, reaching $313.82M last quarter. TTM EBITDA of $182.83M and TTM operating income of $129.26M show growth is flowing through to the bottom line. TTM net income of $86.73M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 3 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 24.4%
EBITDA Margin: 17.9%
Op. Margin: 13.4%
Net Margin: 8.9%

Op. margin of 13.4% is up 1.3% YoY — cost efficiency is improving. Net margin at 8.9% and gross margin of 24.4% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 3 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 36.5x
P/S Ratio: 2.8x
P/B Ratio: 5.6x

At 36.5x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 2.8x and P/B of 5.6x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has fallen for 2 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.01B
Cash: $7.10M
Long-Term Debt: $229.00M
Book Value: $563.69M
D/E Ratio: 0.4
Debt/EBITDA: 4.1

With $1.01B in assets and $229.00M in long-term debt, D/E is 0.4and book value is $563.69M — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has fallen for 4 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

TTM Free Cash Flow: $62.95M
FCF Margin: 5.6%
FCF / Net Income: 0.7

TTM FCF of $62.95M. The FCF / Net Income ratio of 0.7x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is down 16% — a weakening trend.